Title : 18F-FNDP for PET Imaging of Soluble Epoxide Hydrolase - Horti_2016_J.Nucl.Med_57_1817 |
Author(s) : Horti AG , Wang Y , Minn I , Lan X , Wang J , Koehler RC , Alkayed NJ , Dannals RF , Pomper MG |
Ref : J Nucl Med , 57 :1817 , 2016 |
Abstract :
Soluble epoxide hydrolase (sEH) is a bifunctional enzyme located within cytosol and peroxisomes that converts epoxides to the corresponding diols and hydrolyzes phosphate monoesters. It serves to inactivate epoxyeicosatrienoic acids (EETs), which are generated in the brain to couple neuronal activity and cerebral blood flow in normal and pathologic states. Altered regulation of sEH was observed previously in various neuropathologic disorders including vascular dementia and stroke. Inhibitors of sEH are pursued as agents to mitigate neuronal damage after stroke. We developed N-(3,3-diphenylpropyl)-6-18F-fluoronicotinamide (18F-FNDP), which proved highly specific for imaging of sEH in the mouse and nonhuman primate brain with PET. |
PubMedSearch : Horti_2016_J.Nucl.Med_57_1817 |
PubMedID: 27417650 |
Inhibitor | FNDP |
Horti AG, Wang Y, Minn I, Lan X, Wang J, Koehler RC, Alkayed NJ, Dannals RF, Pomper MG (2016)
18F-FNDP for PET Imaging of Soluble Epoxide Hydrolase
J Nucl Med
57 :1817
Horti AG, Wang Y, Minn I, Lan X, Wang J, Koehler RC, Alkayed NJ, Dannals RF, Pomper MG (2016)
J Nucl Med
57 :1817